(Q74592642)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

A subdepressor low dose of ramipril lowers urinary protein excretion without increasing plasma potassium (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

T Keilani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

F R Danesh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

W A Schlueter

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A Molteni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

D Batlle

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070908%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

450-457

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070908%20AND%20SRC:MED&resulttype=core&format=json

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Reduction of proteinuria by angiotensin converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

The effect of angiotensin-converting enzyme inhibition and dietary protein restriction in the treatment of proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

"Intact nephrons" as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Effects of Converting-Enzyme Inhibition on Barrier Function in Diabetic Glomerulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Effects of angiotensin II receptor blockade on remnant glomerular permselectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Effect of ramipril on blood pressure and protein excretion rate in normotensive nondiabetic patients with proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Enalapril Can Treat the Proteinuria of Membranous Glomerulonephritis Without Detriment to Systemic or Renal Hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Selected aspects of ACE inhibitor therapy for patients with renal disease: impact on proteinuria, lipids and potassium

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Independent effects of aldosterone and potassium on induction of potassium adaptation in rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Plasma aldosterone concentrations in chronic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Prevalence, pathogenesis, and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Effect of changes in sodium or potassium balance, and nephrectomy, on adrenal renin and aldosterone concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Production of renin, angiotensin II, and aldosterone by adrenal explant cultures: response to potassium and converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

In vitro tissue potencies of converting enzyme inhibitors. Prodrug activation by kidney esterase

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

Dietary Na and ACE inhibition effects on renal tissue angiotensin I and II and ACE activity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970181-2

7 January 2021

10.1016/S0272-6386(99)70181-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference